John Amory
Corporate Officer/Principal bij University of Washington
Actieve functies van John Amory
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | 01-07-2011 | - |
Loopbaan van John Amory
Eerdere bekende functies van John Amory
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Directeur/Bestuurslid | 01-01-2021 | 31-10-2022 |
| Independent Dir/Board Member | 01-01-2021 | 31-10-2022 | |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Directeur/Bestuurslid | - | - |
Opleiding van John Amory
| The University of California, San Francisco | Doctorate Degree |
| University of Washington | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
- Beurs
- Insiders
- John Amory
- Ervaring
